(PharmaNewsWire.Com, March 22, 2018 ) The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.
Publisher's analysts forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.
The market is divided into the following segments based on geography: -Americas -APAC -EMEA
Publisher's report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors -Apricus Biosciences -Cristalia Produtos Quimicos Farmaceuticos -Dong-A Socio -Endo Pharmaceuticals -Futura Medical -Meda Pharmaceuticals -Promedon -SK Chemical -Teva Pharmaceuticals -Vivus -Zephyr Surgical Implants (ZSI)
Market driver -Demand from older adult male population -For a full, detailed list, view our report
Market challenge -Threat of counterfeit products -For a full, detailed list, view our report
Market trend -Migration of manufacturing and sales facilities to APAC -For a full, detailed list, view our report
Table of Content
PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Global organic personal care market PART 06: Market landscape PART 07: Market segmentation by type PART 08: Geographical segmentation PART 09: Key leading countries PART 10: Market drivers PART 11: Impact of drivers PART 12: Market challenges PART 14: Market trends PART 15: Vendor landscape PART 16: Explore Publisher
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
